Concerto Renal Services
Concerto Renal Services is a US healthcare company that delivers on-site hemodialysis and sub-acute dialysis care to residents of skilled nursing facilities across 17 states, replacing transport to outpatient clinics.
- Company typePrivate
- Founded2015
- HeadquartersLincolnwood, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Concerto Renal Services does
Concerto Renal Services is a US healthcare services company that delivers on-site hemodialysis to residents of skilled nursing facilities (SNFs). Founded in 2015 and headquartered in Lincolnwood, Illinois, the company operates across 17 states through 16 regional offices and self-describes as the largest provider of nursing home dialysis in the United States. Its core service is three-times-weekly hemodialysis delivered inside SNFs, replacing ambulance transport to outpatient clinics for end-stage renal disease (ESRD) patients. The product set spans traditional on-site hemodialysis, sub-acute care for clinically complex patients (ventilator-dependent, tracheostomy, Life-Vest, and AKI), and an Inclusive Care Model under which Concerto supplies all equipment, supplies, and clinical staff on-site. The company overlays a Total Care Coordination (TCC) program — daily communication forms, weekly regional manager meetings, and monthly coordinated care plan meetings — to coordinate dialysis staff with SNF operators.
The business model is fee-for-service: Concerto is reimbursed for dialysis treatments by Medicaid, Medicare Part B, commercial insurance, and HMO/Medicare managed-care plans, and charges a separate staffing supplement to SNF partners whose level varies with program scope and patient acuity. Customer-facing differentiation is grounded in continuity of care with familiar SNF staff, the ability to take clinically complex patients many outpatient centers decline, and the elimination of an estimated $411 per patient-day in ambulance transport costs. Go-to-market is enterprise B2B: a dedicated field-sales team and intake specialists (available seven days a week) work directly with SNF operators and hospital discharge planners to set up on-site dialysis programs.
Revenue, funding, and patient census are not disclosed in the available data. The company is a privately held LLC led by founder/CEO Shimon Meystel, with a full executive team covering finance, operations, medical, legal, HR, quality, and learning. No acquisitions, institutional funding rounds, or partnerships are disclosed in the input; growth has been funded organically inside the 17-state footprint.
Concerto Renal Services firmographics
Firmographics- Name
- Concerto Renal Services
- Legal name
- Concerto Renal Services LLC
- Website
- https://concertors.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Concerto Renal Services is a US healthcare company that delivers on-site hemodialysis and sub-acute dialysis care to residents of skilled nursing facilities across 17 states, replacing transport to outpatient clinics.
- Ownership category
- akta.pro rank
Concerto Renal Services industry classification
Industry- Product category
- Nursing Home Dialysis Services
- NAICS
- Kidney Dialysis Centers (621492), Nursing Care Facilities (Skilled Nursing Facilities) (62311)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)
- akta.pro primary industry
- Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)
- akta.pro secondary industry
- Dialysis-Capable / Renal Care SNFs (HLADADAK)
Keywords
Where Concerto Renal Services is headquartered
LocationHeadquarters
- HQ city
- Lincolnwood
- HQ country
- United States
- HQ region
- North America
Offices17 records
Markets served
Concerto Renal Services business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Healthcare Services - Dialysis Treatment: Fee-for-service revenue from providing hemodialysis treatments to SNF residents. Services are paid by Medicaid, Medicare Part B, insurance, and HMO/Medicare managed-care plans. The company also charges a staffing supplement for their on-site dialysis program services.
- Staffing Supplement: A fee charged to nursing home partners for staffing and operational support of the dialysis program. The fee varies depending on program vision and level of care required.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Insurance/Government-funded treatment |
| Other | Monthly | Staffing supplement for SNF partners |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Concerto Renal Services product offering
Product offeringCore offering
Concerto Renal Services delivers on-site hemodialysis treatment directly to residents of skilled nursing facilities (SNFs), eliminating the need to transport elderly ESRD patients to outpatient dialysis clinics. The company supplies all equipment, supplies, and clinical staff, and operates across 17 states with specialized capability for clinically complex patients including ventilator-dependent, tracheostomy, and AKI cases. Revenue is generated through fee-for-service treatments reimbursed by Medicare Part B, Medicaid, commercial insurance, and managed-care plans, plus a staffing supplement paid by SNF partners.
Product overview
Concerto Renal Services offers a unified nursing home dialysis care platform centered on on-site hemodialysis services delivered directly within skilled nursing facilities. The core offering includes traditional three-times weekly hemodialysis treatment for ESRD patients, supplemented by sub-acute dialysis care for clinically complex cases (ventilator-dependent, tracheostomy, AKI patients). The company operates vent dialysis units and provides an Inclusive Care Model delivering all supplies, equipment, and clinical staff. Total Care Coordination (TCC) coordinates care across doctors, nurses, physical/occupational therapists, renal dietitians, and social workers. Concerto accepts Medicaid, Medicare Part B, insurance, and managed-care plans, with instant admissions capabilities and dedicated intake specialists available 7 days per week.
Differentiator
Problem solved
Functional benefit
Products and services
- On-Site Hemodialysis Services Traditional three-times weekly hemodialysis treatment delivered on-site at skilled nursing facilities, allowing SNF residents to receive dialysis in their residence rather than being transported to outpatient clinics. Includes all supplies, equipment, and clinical staff required for treatment.
- Sub-Acute Dialysis Care Specialized on-site dialysis care for clinically complex patients including those with acute kidney injury (AKI), Life-Vest needs, tracheostomy, and ventilator dependence. Includes operation of vent dialysis units capable of treating highly acute patients that many outpatient clinics decline to serve.
- Inclusive Care Model Comprehensive service delivery program in which Concerto provides all supplies, equipment, and human resources needed for dialysis care, including renal dietitians, renal social workers, and dialysis clinical staff working within the nursing home. Designed to remove operational burden from SNF partners.
Quantifiable outcome
- $411 average ambulance cost per patient-day eliminated through on-site treatment
- +1 more outcomes
Companies that use Concerto Renal Services
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
Concerto Renal Services technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Concerto Renal Services partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Concerto Renal Services competitors and assessment
Company assessmentEmerging players
- Somatus: Somatus is a value-based kidney care company providing integrated CKD and ESRD care management to health plans and provider systems. It is comparable as an emerging competitor addressing the same ESRD patient population through a different delivery and payment model.
- Strive Health: Strive Health is a value-based kidney care company partnering with providers and payers to manage CKD and ESRD patients. While not a direct in-SNF dialysis operator, it competes for kidney care economics and is shaping how dialysis is delivered to complex patient populations.
Direct peers
- Satellite Healthcare: Satellite Healthcare is a non-profit dialysis provider operating outpatient centers with a strong focus on patient quality of life and chronic kidney disease programs. It is comparable as a multi-site dialysis provider serving geriatric and complex patient populations.
- Centers for Dialysis Care: Centers for Dialysis Care is a non-profit dialysis provider offering in-center, home, and SNF-based dialysis services with strong focus on patient outcomes. It is comparable as a multi-modality dialysis provider serving geriatric and SNF populations in select geographies.
- Dialyze Direct: Dialyze Direct is the closest direct competitor to Concerto, providing on-site hemodialysis services to skilled nursing facility residents with a geriatric-focused care model and a multi-state footprint. It competes head-to-head for the same SNF contracts and clinical complex patient populations.
- Atlantic Dialysis Management Services: Atlantic Dialysis Management Services operates multiple outpatient dialysis centers across the US with a community-based care model, including services to skilled nursing and long-term care settings. It is comparable as a multi-site dialysis provider serving SNF residents.
Broad incumbents
- DaVita Kidney Care: DaVita is the largest US outpatient dialysis provider with thousands of clinics nationwide and deep nephrologist relationships. While its core business is outpatient, it has the scale and capital to enter or expand into the SNF dialysis channel that Concerto has built.
- U.S. Renal Care: U.S. Renal Care is a mid-large national outpatient dialysis provider that has pursued growth through both organic expansion and acquisitions. It is comparable as a multi-state dialysis services competitor that could expand into the SNF segment.
- Fresenius Kidney Care: Fresenius is the other dominant US outpatient dialysis incumbent, with a national clinic footprint, vertically integrated supplies and equipment manufacturing, and significant clinical resources. It competes for the same ESRD patient population that Concerto serves in SNFs.
- American Renal Associates (now Innovative Renal Care): American Renal Associates, now operating as Innovative Renal Care following its take-private, is a national outpatient dialysis chain with community-based centers. It is a broad incumbent competitor serving the same ESRD patient population.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Concerto Renal Services social profiles
Digital presenceConcerto Renal Services financial estimates
Financial estimateRevenue estimate
Valuation estimate
Concerto Renal Services leadership team
Management profileNumber of profiles
Profiles14 records
Concerto Renal Services funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Concerto Renal Services M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Concerto Renal Services
What does Concerto Renal Services do?
Concerto Renal Services delivers on-site hemodialysis treatment directly to residents of skilled nursing facilities (SNFs), eliminating the need to transport elderly ESRD patients to outpatient dialysis clinics. The company supplies all equipment, supplies, and clinical staff, and operates across 17 states with specialized capability for clinically complex patients including ventilator-dependent, tracheostomy, and AKI cases. Revenue is generated through fee-for-service treatments reimbursed by Medicare Part B, Medicaid, commercial insurance, and managed-care plans, plus a staffing supplement paid by SNF partners.
Is Concerto Renal Services a public or private company?
Concerto Renal Services is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Concerto Renal Services founded?
Concerto Renal Services was founded in 2015. It employs 251 to 500 people.
Where is Concerto Renal Services based?
Concerto Renal Services is headquartered in Lincolnwood, United States, in the North America region.
How does Concerto Renal Services make money?
Two revenue lines are on record. Healthcare Services - Dialysis Treatment is the primary driver. The others are staffing Supplement.
Who are Concerto Renal Services's main competitors?
Emerging players on record are Somatus and Strive Health. Direct peers are Satellite Healthcare, Centers for Dialysis Care, Dialyze Direct and Atlantic Dialysis Management Services. Broad incumbents are DaVita Kidney Care, U.S. Renal Care, Fresenius Kidney Care and American Renal Associates (now Innovative Renal Care).
Does Concerto Renal Services have an API?
No public API is recorded for Concerto Renal Services.
What industry is Concerto Renal Services in?
Concerto Renal Services's product category is Nursing Home Dialysis Services. Its primary akta.pro industry code is HLAKAHAC, Dialysis Services (Hemodialysis & Peritoneal Dialysis), with a secondary code of HLADADAK, Dialysis-Capable / Renal Care SNFs. Its NAICS code is 621492 and its SIC code is 8093.